F. Baldinetti

754 total citations
17 papers, 542 citations indexed

About

F. Baldinetti is a scholar working on Experimental and Cognitive Psychology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, F. Baldinetti has authored 17 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Experimental and Cognitive Psychology, 7 papers in Pharmacology and 6 papers in Psychiatry and Mental health. Recurrent topics in F. Baldinetti's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (8 papers), Treatment of Major Depression (6 papers) and Child and Adolescent Psychosocial and Emotional Development (2 papers). F. Baldinetti is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (8 papers), Treatment of Major Depression (6 papers) and Child and Adolescent Psychosocial and Emotional Development (2 papers). F. Baldinetti collaborates with scholars based in United States, United Kingdom and Italy. F. Baldinetti's co-authors include Francine S. Mandel, Krai Chatamra, L. Pauer, Stuart Montgomery, Ed Whalen, Carlo Caltagirone, Gianfranco Spalletta, Atul C. Pande, Douglas E. Feltner and David S. Baldwin and has published in prestigious journals such as Neurology, The British Journal of Psychiatry and Clinical Chemistry.

In The Last Decade

F. Baldinetti

17 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Baldinetti United States	10	224	214	138	130	92	17	542
Maria Liu-Dumaw United States	6	164 0.7×	269 1.3×	170 1.2×	155 1.2×	80 0.9×	8	573
Daniel L. Zimbroff United States	4	114 0.5×	150 0.7×	103 0.7×	126 1.0×	44 0.5×	5	436
Christian Barnas Austria	13	230 1.0×	78 0.4×	101 0.7×	70 0.5×	31 0.3×	25	515
Jerri G. Crockatt United States	7	529 2.4×	307 1.4×	215 1.6×	204 1.6×	88 1.0×	9	1.0k
Raymond F. Anton United States	7	103 0.5×	109 0.5×	62 0.4×	150 1.2×	42 0.5×	9	802
Craig Q. Earl United States	13	266 1.2×	85 0.4×	76 0.6×	59 0.5×	46 0.5×	17	559
Javier Vázquez-Bourgón Spain	16	464 2.1×	59 0.3×	86 0.6×	142 1.1×	88 1.0×	77	793
Ahsan Y. Khan United States	10	188 0.8×	124 0.6×	154 1.1×	59 0.5×	35 0.4×	25	467
J. Liappas Greece	12	154 0.7×	61 0.3×	79 0.6×	77 0.6×	54 0.6×	30	464
Maria Antonietta Nettis United Kingdom	14	132 0.6×	51 0.2×	73 0.5×	70 0.5×	49 0.5×	28	766

Countries citing papers authored by F. Baldinetti

Since Specialization

Citations

This map shows the geographic impact of F. Baldinetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Baldinetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Baldinetti more than expected).

Fields of papers citing papers by F. Baldinetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Baldinetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Baldinetti. The network helps show where F. Baldinetti may publish in the future.

Co-authorship network of co-authors of F. Baldinetti

This figure shows the co-authorship network connecting the top 25 collaborators of F. Baldinetti. A scholar is included among the top collaborators of F. Baldinetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Baldinetti. F. Baldinetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lunven, Catherine, et al.. (2017). Effectiveness and Tolerability of Colesevelam HCl for Accelerated Elimination of Teriflunomide in Healthy Participants. The Journal of Clinical Pharmacology. 57(6). 747–750. 2 indexed citations

Lunven, Catherine, et al.. (2016). Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide. Therapeutic Drug Monitoring. 38(4). 471–482. 14 indexed citations

Vermersch, Patrick, Óscar Fernández, F. Baldinetti, et al.. (2015). Evaluation of Comprehensive Alemtuzumab Infusion Guidance in Patients With Relapsing-Remitting Multiple Sclerosis: EMERALD Study Design (P7.283). Neurology. 84(14_supplement). 1 indexed citations

Brinar, Vesna, Gavin Giovannoni, Eva Havrdová, et al.. (2015). A Phase 3b/4 Long-Term Study of Alemtuzumab in Patients With Relapsing-Remitting Multiple Sclerosis: TOPAZ Study Design (P7.219). Neurology. 84(14_supplement). 3 indexed citations

Kasper, Siegfried, Barry K. Herman, Michael Van Ameringen, et al.. (2009). Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial. International Clinical Psychopharmacology. 24(2). 87–96. 65 indexed citations

Gil‐Nagel, António, Gaetano Zaccara, F. Baldinetti, & Teresa León. (2008). Add-on treatment with pregabalin for partial seizures with or without generalisation: Pooled data analysis of four randomised placebo-controlled trials. Seizure. 18(3). 184–192. 28 indexed citations

Stein, Dan J., David S. Baldwin, F. Baldinetti, & Francine S. Mandel. (2008). Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: A pooled analysis of 6 studies. European Neuropsychopharmacology. 18(6). 422–430. 57 indexed citations

Feltner, Douglas E., et al.. (2008). Long-term efficacy of pregabalin in generalized anxiety disorder. International Clinical Psychopharmacology. 23(1). 18–28. 83 indexed citations

Montgomery, Stuart, Krai Chatamra, L. Pauer, Ed Whalen, & F. Baldinetti. (2008). Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. The British Journal of Psychiatry. 193(5). 389–394. 90 indexed citations

10.

Nutt, D.J., Francine S. Mandel, & F. Baldinetti. (2008). Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model. Journal of Psychopharmacology. 23(8). 867–873. 37 indexed citations

11.

Carrasco, Melisa, et al.. (2007). Preliminary results evaluating cognitive function in elderly from double-blind, placebo-controlled trial of pregabalin in generalized anxiety disorder (gad). European Psychiatry. 22. S279–S280. 2 indexed citations

12.

Bobes, Julio, Stuart Montgomery, F. Baldinetti, et al.. (2007). Pregabalin for the treatment of generalized anxiety disorder (GAD): Efficacy and safety in elderly patients. European Psychiatry. 22. S280–S280. 1 indexed citations

13.

Montgomery, S.A., et al.. (2006). P.4.a.020 Efficacy and safety of pregabalin for the treatment of generalized anxiety disorder in elderly patients. European Neuropsychopharmacology. 16. S458–S459. 2 indexed citations

14.

Bernardini, Sergio, Lorenza Bellincampi, Giorgio Federici, et al.. (2005). Glutathione S-Transferase P1 *C Allelic Variant Increases Susceptibility for Late-Onset Alzheimer Disease: Association Study and Relationship with Apolipoprotein E ε4 Allele. Clinical Chemistry. 51(6). 944–951. 43 indexed citations

15.

Spalletta, Gianfranco, F. Baldinetti, Ivana Buccione, et al.. (2004). Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer?s disease. Journal of Neurology. 251(6). 688–95. 85 indexed citations

16.

Tettamanti, Mauro, F. Baldinetti, Pierfrancesco Ruffo, et al.. (2000). Donepezil Italian global impact study (DIGIS). Neurobiology of Aging. 21. 239–239. 3 indexed citations

17.

Gigli, Gian Luigi, Marina Diomedi, Alfonso Troisi, et al.. (1994). Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy. Seizure. 3(3). 221–224. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact